SinoMab Announces the Completion of Enrollment in Phase III

SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03

SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , , Sinomab Bioscience , Significant New Drugs Development Of The Twelfth , Asia Corporate News Network , Sinomab Bioscience Limited , Sinomab Announces , Flagship Product , Mab Bioscience Limited , Hong Kong Based , Executive Director , Chief Executive Officer , Significant New Drugs Development , Twelfth Five Year Plan Period , Thirteenth Five Year Plan , Asia Corporate News ,